MSH2 and brain neoplasm: CNS tumors, as an extracolonic manifestation of LS, appear to be relatively infrequent, with the occurrence risk quadrupling, and the cumulative lifetime risk of brain tumors is significantly greater in individuals with MSH2 mutations than in those with variants in other MMR genes28,37,38.